|
BIO Videos and Audio
Roundtable for Journalists on How Industrial Biotechnology Creates Cleaner, Sustainable Businesses
Brent Erickson, executive vice president, BIO; Brian Igoe, vice president and chief brand officer, Metabolix; Glenn Nedwin, executive vice president, technical enzymes, Genencor Division of Danisco; Andy Shafer, executive vice president for sales & marketing, Elevance; Nicolas Denis, associate principal, McKinsey & Company; and David Lundy, project leader, Elizabeth Nesbitt and Laura Polly, deputy project leaders, U.S. International Trade Commission provide background on how industrial biotechnology will be critical to the future productivity and competitiveness of U.S. chemical and liquid biofuels firms because it helps companies innovate and improve environmental performance.
Listen to the teleconference
BioTech Nation Interview of Jim Greenwood (June 4, 2007)
Dr. Moira Gunn and David Ewing Duncan report from the BIO International Convention. There, they speak with Peggy Willocks, a Parkinson's patient who's undergone an innovative new procedure, and do a conference wrap-up with BIO President and CEO Jim Greenwood.
Listen now (28 min. MP3)
Videos from the Globe at BIO 2007 (April 6-9, 2007)
Alzheimer's: Searching for an end to a dreaded disease
Searching for New Drugs: Discovering New Drug Therapies in the Amazon Rainforest
American Agricultures: World's Most Productive Farms
Asian Biotech Centers: Asian Countries Rapidly Embracing the New Frontier
Biofuels: Producing Clean, Reliable and Sustainable Energy
Immunotherapies: Creating New Tools to Fight Cancer and Other Diseases
Cotton: Providing Farmers the Tools to Save India's Most Important Export
Industrial Enzymes: Using Nature to Improve the Environment, Protect our Resources and Create Economic Opportunities
Avian Flu: Preparing for a Worldwide Pandemic
Malaria: Finding a Cure for 300 Million infected and 1 million deaths annually
Personal Nutrition: Creating a New Dietary Approach to Improving Individual Health
RNAi: Creating a New Approach to Medicine
Sorghum: Responding to the Health and Economic Challenges of Developing Nations
Roundtable for Journalists on How Biotechnology Can Help Boost Yields of Both Food, Feed, Fiber and Advanced Biofuels (June 2008)
Brent Erickson, executive vice president, Industrial and Environmental Section, BIO; Tom West, vice president, Business and Community Support, Pioneer and director, Biotechnology Affairs, DuPont; Kelly Lindenboom, vice president, Corporate Communications, Verenium; and Nathan Ramsey, director, Business Development, ArborGen LLC provide information on the biotechnology advances that will make possible increased production of food, feed, fiber and biofuels.
Listen to the teleconference
Roundtable for Journalists on How the Farm Bill’s Energy Provisions Can Help Accelerate Low-Carbon Biofuels Production
Brent Erickson, executive vice president of BIO’s Industrial & Environmental Section; Anna Rath, vice president of commercial development, Ceres, Inc.; Darrin Ihnen, South Dakota farmer; and Jack Huttner, vice president of biorefinery development, Genencor, a division of Danisco, discuss key programs in the recently enacted Farm Bill, including loan guarantees to assist the construction of commercial biorefineries for production of advanced biofuels; a Biomass Crop Assistance Program that will help farmers transition to growing cellulosic energy crops; and funding for research and development into making advanced, low-carbon biofuels cost-competitive for consumers.
Listen to the teleconference
Roundtable for Journalists on Advanced Biofuel Technology for DOE Small-Scale Biorefinery Grants (February 21, 2008)
Brent Erickson, Executive Vice President, Industrial and Environmental Section, BIO; Anna Rath, Vice President, Commercial Development, Ceres; Emmanuel Petiot, Global Biomass Business Development Manager, Novozymes North America; and Matt Carr, Director of Policy, BIO discuss the rapid advances in technology that are making DOE-backed demonstration biorefinery processes to convert cellulosic biomass to biofuels and biobased chemicals and products economical, energy efficient and environmentally beneficial.
Listen to the teleconference
Roundtable for Journalists on the Implications of the Energy Independence and Security Act of 2007 (December 20, 2007)
Brent Erickson, executive vice president, Industrial and Environmental Section, BIO); William K. Caesar, partner, and Jens Riese, partner, McKinsey & Company; Gerson Santos, VP Research and Development, Abengoa Bioenergy and Dr. Mark Stowers, VP of Research & Development, POET examine the far-reaching implications of the new renewable fuels standard contained in the Energy Independence and Security Act of 2007.
Listen to teleconference
BIOLive™ The Importance of Biotechnology In Addressing The Obesity Epidemic (October 29, 2007)
A distinguished panel discusses the current treatment options for obesity, as well as the needs and hopes of both patients and physicians to better address this growing epidemic. William Rowley, MD, Senior Futurist & Chief Operating Officer, Institute for Alternative Futures and others cover the prevalence, challenges and the impact of obesity, and describe the future - the role of biotechnology - where the science is headed, and the range of treatments coming from new technologies.
Watch the web cast
Biotech Fashion Show (July 2006)
A fashion show at the recent World Congress on Industrial Biotechnology and Bioprocessing featured both ready-to-wear clothing and designer gowns -- including some made by top fashion designers Halston, Oscar de la Renta, Stephen Burrows, Heatherette, and Elisa Jimenez -- made with IngeoTM fabric. IngeoTM is spun from polylactide (PLA), a compostable biopolymer made from dextrose corn sugar that is fermented in a biotech process. The fashion show highlighted the diversity of biobased products made with industrial biotechnology currently available to consumers, including plastics, food ingredients, and fuels.
Watch the video (WMV 8 min.)
The Role of Biotechnology in Biodefense Preparedness (July 2006)
Biotechnology is providing a wide variety of solutions to bioterrorist threats. This July briefing on Capitol Hill covered a range of technologies for biodefense preparedness, from research tools and diagnostics to vaccine technologies, to a broad range of therapeutics. With sound policies and a strong public-private partnership, the biotechnology industry can provide the hope, and real benefits, needed to protect the citizenry from potential threats. Presenters include James M. Meegan, Ph.D., Senior Director, Biodefense, Invitrogen; Una S. Ryan, Ph.D., O.B.E., President & CEO, AVANT Immunotherapeutics; Dennis E. Hruby, Ph.D., Chief Scientific Officer, Pharmathene; Elizabeth Posillico, Ph.D., President & CEO, Elusys Therapeutics; and Richard Hamburg, Director, Government Relations, Trust for America's Health.
Watch the video (WMV 50 min.)
Biotechnology Improves the Lives of People with Autoimmune Diseases (Jan. 2006)
BIO hosts a Capitol Hill briefing on autoimmune disease. Sandra Raymond of The Lupus Foundation of America; JingsonWang, Translational Medicine, Wyeth Research; John Klippel of the Arthritis Foundation; Steve Engle, chairman & CEO, La Jolla Pharmaceutical Co.; and Brent Del Monte, vice president of federal government relations, at BIO discuss how biotechnology has contributed to the development of life-saving products and therapies for lupus, rheumatoid arthritis, multiple sclerosis, CrohnÃs disease and other disorders. The panelists covered the prevalence, challenges and impact of autoimmune diseases and the range of treatments coming from new technologies.
Watch the video (1 hour Windows Media Video)
BIO Commends House for Passage of Stem Cell Research Enhancement Act (May 24, 2005)
Jim Greenwood, president of the Biotechnology Industry Organization (BIO), issued the following statement on H.R. 810, the Stem Cell Research Enhancement Act, which was passed in the U.S. House of Representatives today by a vote of 238-194.
Read the press release
Watch Jim Greenwood's statement (2 min. Windows Media Video)
Animals and Medicine (March 2005)
This video highlights the many advances in biotechnology that benefit companion animals and livestock. From biotech-derived vaccines, medicines, and diagnostic tests to the mapping of animal genomes, biotechnology has improved animal health along with human health care and promises to improve animal well-being in the future. Research involving animals has been critical to understanding the fundamental processes of human biology that are so integral to modern medicine. Virtually every major medical advance of the last century has depended upon research with animals.
Watch the program (22 min. Windows Media Video)
New Biotech Processes Revolutionize Domestic Energy Production (February 21, 2005)
This video introduces a revolution in industrial biotechnology that is radically changing how companies make ethanol for transportation fuel. The key driver in this new technology is the ability to change the cellulose in agricultural crop plant matter into sugars that can be fermented to produce ethanol and refined into other value-added products.
Industrial biotechnology companies have developed microbes that now make it economically feasible to produce ethanol not only from grain but also from corn stover, wheat straw, sugar cane waste and many other agricultural crop residues.
Watch the program (20 min. Windows Media Video)
Watch highlights of the program (2 min. Windows Media Video)
Key Points About Plant-Made Pharmaceuticals
Andrew Baum, President & CEO, SemBioSys Genetics, Inc., discusses plant-made pharmaceuticals on BIO LiveTM, a special web cast program.
Watch the program (13 min. Windows Media Video)
Read key points from the program
BIO Television Ads
|
